Sundaram Multi Pap Board Meeting on March 5 to Address SLAPL Share Swap Withdrawal

2 min read     Updated on 28 Feb 2026, 03:23 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Sundaram Multi Pap Limited has scheduled a board meeting for March 5, 2026, following SLAPL's formal withdrawal from a proposed ₹235.90 crore share swap transaction. The withdrawal comes after the company's share price declined significantly from ₹3.35 to ₹1.52 per share over 107 days since EGM approval, prompting SLAPL to cite material changes in market conditions.

33818030

*this image is generated using AI for illustrative purposes only.

Sundaram Multi Pap Limited has announced a board meeting scheduled for March 5, 2026, at 11:00 AM to address the formal withdrawal of a significant share swap transaction by Sundaram Land and Assets Private Limited (SLAPL). The meeting follows SLAPL's official communication dated February 27, 2026, expressing its decision not to proceed with the previously approved transaction.

Regulatory Compliance and Meeting Details

In compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has formally notified BSE Limited and National Stock Exchange of India Limited about the board meeting. The notification was signed by Managing Director & Chairman Amrut Premji Shah and submitted to both exchanges on February 28, 2026.

Meeting Details: Information
Date: March 5, 2026
Time: 11:00 AM
BSE Scrip Code: 533166
NSE Symbol: SUNDARAM
Regulation: SEBI (LODR) Regulations, 2015

Original Transaction Structure

The proposed transaction involved the issuance of 7,04,00,000 equity shares of Sundaram Multi Pap Limited at ₹3.35 per share, approved by shareholders at the Extraordinary General Meeting held on November 12, 2025. Through this share swap mechanism, the company intended to acquire a 52.38% stake in SLAPL.

Transaction Parameters: Details
Share Issue: 7,04,00,000 equity shares
Issue Price: ₹3.35 per share
Stake Acquisition: 52.38% in SLAPL
EGM Approval Date: November 12, 2025
Transaction Value: ₹235.90 crore

Market Conditions and Price Impact

SLAPL's board cited material changes in prevailing market conditions as the primary reason for withdrawal. The most significant factor was the substantial decline in Sundaram Multi Pap's share price, which dropped from the originally proposed swap price of ₹3.35 per share to ₹1.52 per share as of February 27, 2026.

Price Analysis: Amount
Original Swap Price: ₹3.35 per share
Market Price (Feb 27, 2026): ₹1.52 per share
Price Decline: ₹1.83 per share
Percentage Decline: 54.63%
Days Since EGM: 107 days

SLAPL's Formal Position

In its official communication to Sundaram Multi Pap's Board of Directors, SLAPL stated that after due deliberation and in the interest of safeguarding shareholder value, the board resolved not to proceed with the proposed transaction in its current form. The company emphasized that the effective economic value of the originally proposed share swap consideration had materially reduced when compared to prevailing market indicators, including the 52-week price range of SMPL shares.

SLAPL attributed the withdrawal to delays in obtaining requisite approvals and expressed openness to evaluating future proposals that may be mutually beneficial and commercially aligned, subject to fresh consideration and approvals as required.

Board Meeting Agenda and Next Steps

The board meeting will focus on considering and evaluating SLAPL's withdrawal communication and determining appropriate decisions in relation to the withdrawal. The company has committed to intimating the stock exchanges about the board meeting outcome in accordance with applicable regulations. This development represents a significant shift in the company's expansion strategy and may require reassessment of its growth plans involving SLAPL.

Historical Stock Returns for Sundaram Multi Pap

1 Day5 Days1 Month6 Months1 Year5 Years
-2.58%-6.79%-4.43%-24.88%-28.10%+16.15%

Sundaram Multi Pap Limited Board Approves Q3 FY26 Unaudited Standalone Financial Results

1 min read     Updated on 14 Feb 2026, 02:32 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Sundaram Multi Pap Limited successfully conducted its board meeting on February 14, 2026, approving unaudited standalone financial results for Q3 FY26 and nine months ended December 31, 2025. The meeting was presided over by Chairman & Managing Director Amrut P Shah and fulfilled all regulatory requirements under SEBI Regulation 33, with formal communications sent to BSE and NSE.

32605334

*this image is generated using AI for illustrative purposes only.

Sundaram Multi Pap Limited has announced the successful completion of its board meeting held on February 14, 2026, where key financial results were approved for the third quarter of fiscal year 2026. The meeting took place at the company's premises located at 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai, spanning three hours from 11:00 AM to 2:00 PM.

Board Meeting Details and Venue

The board meeting was conducted under the leadership of Chairman & Managing Director Amrut P Shah, who holds DIN 00033120. The meeting was held in compliance with regulatory requirements and followed the intimation submitted to stock exchanges on February 6, 2026.

Meeting Parameter: Details
Date: February 14, 2026
Commencement Time: 11:00 AM
Conclusion Time: 2:00 PM
Venue: 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai 400093
Presiding Officer: Amrut P Shah, Chairman & Managing Director

Financial Results Approval

The primary agenda of the board meeting focused on the consideration and approval of unaudited standalone financial results. The directors approved the financial performance data for both the quarter and nine months ended December 31, 2025, marking the completion of Q3 FY26 reporting requirements.

The financial results were prepared in accordance with applicable accounting standards and were accompanied by a Limited Review Report issued by the company's auditors. This approval ensures compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance and Documentation

The company has fulfilled its regulatory obligations by formally communicating the board meeting outcome to both BSE Limited and National Stock Exchange of India Limited. The communication was digitally signed by Chairman & Managing Director Amrut P Shah on February 14, 2026, at 14:09:27 +05'30', ensuring proper documentation and timestamp verification.

Exchange Details: Information
BSE Scrip Code: 533166
NSE Symbol: SUNDARAM
Regulation Reference: SEBI Regulation 33
Reporting Period: Quarter and nine months ended December 31, 2025

The approval of these unaudited standalone financial results represents a significant milestone in the company's quarterly reporting cycle, providing stakeholders with updated financial information for the third quarter and nine-month period of fiscal year 2026.

Historical Stock Returns for Sundaram Multi Pap

1 Day5 Days1 Month6 Months1 Year5 Years
-2.58%-6.79%-4.43%-24.88%-28.10%+16.15%

More News on Sundaram Multi Pap

1 Year Returns:-28.10%